RespireRx Pharmaceuticals Inc. Executives Participating in the 2nd Annual International Cannabinoid Derived Pharmaceuticals Summit


You May Also Like

RedHill Biopharma Announces Availability of Its Annual Report on Form 20-F Through Its Website

TEL-AVIV, Israel, Feb. 25, 2016 (GLOBE NEWSWIRE) -- RedHill Biopharma Ltd. (NASDAQ:RDHL) (TASE:RDHL) (“RedHill” ...

Nuritas Announces Formation of Scientific Advisory Board

DUBLIN, Ireland, Oct. 09, 2018 (GLOBE NEWSWIRE) -- Nuritas, a biotechnology company discovering life-changing ...